Literature DB >> 12730112

A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome.

Catherine Lacout1, Elie Haddad, Siham Sabri, Fedor Svinarchouk, Loic Garçon, Claude Capron, Adlen Foudi, Rym Mzali, Scott B Snapper, Fawzia Louache, William Vainchenker, Dominique Duménil.   

Abstract

A defect in cell trafficking and chemotaxis plays an important role in the immune deficiency observed in Wiskott-Aldrich syndrome (WAS). In this report, we show that marrow cells from WAS protein (WASP)-deficient mice also have a defect in chemotaxis. Serial transplantation and competitive reconstitution experiments demonstrated that marrow cells, including hematopoietic progenitors and stem cells (HSCs), have decreased homing capacities that were associated with a defect in adhesion to collagen. During development, HSCs migrate from the liver to the marrow and the spleen, prompting us to ask if a defect in HSC homing during development may explain the skewed X-chromosome inactivation in WAS carriers. Preliminary evidence has shown that, in contrast to marrow progenitor cells, fetal liver progenitor cells from heterozygous females had a random X-chromosome inactivation. When fetal liver cells from WASP-carrier females were injected into irradiated recipients, a nonrandom inactivation of the X-chromosome was found at the level of hematopoietic progenitors and HSCs responsible for the short- and long-term hematopoietic reconstitution. Therefore, the mechanism of the skewed X-chromosomal inactivation observed in WAS carriers may be related to a migration defect of WASP-deficient HSCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730112     DOI: 10.1182/blood-2002-07-2099

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

Review 1.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

Review 2.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

3.  WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.

Authors:  Lisa S Westerberg; Miguel A de la Fuente; Fredrik Wermeling; Hans D Ochs; Mikael C I Karlsson; Scott B Snapper; Luigi D Notarangelo
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

4.  Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.

Authors:  Stephanie Humblet-Baron; Blythe Sather; Stephanie Anover; Shirly Becker-Herman; Debora J Kasprowicz; Socheath Khim; Thuc Nguyen; Kelly Hudkins-Loya; Charles E Alpers; Steve F Ziegler; Hans Ochs; Troy Torgerson; Daniel J Campbell; David J Rawlings
Journal:  J Clin Invest       Date:  2007-01-11       Impact factor: 14.808

5.  A novel WASP gene mutation in a Chinese boy with Wiskott-Aldrich syndrome.

Authors:  Hongtao Yu; Ting Liu; Wentong Meng; Li Hou
Journal:  Int J Hematol       Date:  2010-08-04       Impact factor: 2.490

6.  Genetic deletion of Cdc42GAP reveals a role of Cdc42 in erythropoiesis and hematopoietic stem/progenitor cell survival, adhesion, and engraftment.

Authors:  Lei Wang; Linda Yang; Marie-Dominique Filippi; David A Williams; Yi Zheng
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

7.  Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development.

Authors:  Vinicius Cotta-de-Almeida; Lisa Westerberg; Michel H Maillard; Dilek Onaldi; Heather Wachtel; Parool Meelu; Ung-il Chung; Ramnik Xavier; Frederick W Alt; Scott B Snapper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

Review 8.  Rho GTPases in hematopoiesis and hemopathies.

Authors:  James C Mulloy; Jose A Cancelas; Marie-Dominique Filippi; Theodosia A Kalfa; Fukun Guo; Yi Zheng
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

9.  Wiskott-Aldrich syndrome protein-deficient hematopoietic cells can be efficiently mobilized by granulocyte colony-stimulating factor.

Authors:  Sabine Charrier; Michael Blundell; Gregory Cédrone; Fawzia Louache; William Vainchenker; Adrian J Thrasher; Anne Galy
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

10.  Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells.

Authors:  Alexander Astrakhan; Hans D Ochs; David J Rawlings
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.